Patents by Inventor Ulf Vellmar

Ulf Vellmar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aqueous composition comprising phosphorous and nitrogen for general fire control
    Patent number: 9919174
    Abstract: The present invention discloses a composition and the use of the same in fire control applications. The composition comprises a compound of Formula I or any negatively charged deprotonated form thereof or mixtures thereof, a compound of Formula IIa or IIb or any positively charged or tautomeric form thereof or mixtures thereof and a booster. The booster is selected from the group consisting of a hydrophobic component, an amphiphilic component, a rheology modifier and any mixture thereof. Methods for production are also disclosed.
    Type: Grant
    Filed: September 29, 2013
    Date of Patent: March 20, 2018
    Assignee: FLAME SECURITY SWEDEN AB
    Inventor: Ulf Vellmar
  • AQUEOUS COMPOSITION COMPRISING PHOSPHOROUS AND NITROGEN FOR GENERAL FIRE CONTROL
    Publication number: 20150251034
    Abstract: The present invention discloses a composition and the use of the same in fire control applications. The composition comprises a compound of Formula I or any negatively charged deprotonated form thereof or mixtures thereof, a compound of Formula IIa or IIb or any positively charged or tautomeric form thereof or mixtures thereof and a booster. The booster is selected from the group consisting of a hydrophobic component, an amphiphilic component, a rheology modifier and any mixture thereof. Methods for production are also disclosed.
    Type: Application
    Filed: September 29, 2013
    Publication date: September 10, 2015
    Inventor: Ulf Vellmar
  • Anthranilic acid derivatives
    Patent number: 8461205
    Abstract: Compounds of formula (I) are provided, wherein X is CH?CH, CH2O wherein the oxygen atom is bound to ring B, or OCH2 wherein the oxygen atom is bound to ring A; Y is hydrogen, straight or branched C1-C6 alkyl or a pharmaceutically acceptable inorganic cation; R1 is ethyl or cyclopropyl; and R2 and R3 are the same or different and are selected from F, Cl, Br, CF3 and OCF3. The compounds are useful for the treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection, and malignant neoplasia. Pharmaceutical compositions containing the compounds, methods of using the compounds, and methods for preparing the compounds are also provided.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: June 11, 2013
    Assignee: Chelsea Therapeutics, Inc.
    Inventors: Helén Tuvesson Andersson, Ulf Vellmar, Ingrid Hallin, Leif Svenson, Ingela Fritzson
  • ANTHRANILIC ACID DERIVATIVES
    Publication number: 20120283326
    Abstract: Compounds of formula (I) are provided, wherein X is CH?CH, CH2O wherein the oxygen atom is bound to ring B, or OCH2 wherein the oxygen atom is bound to ring A; Y is hydrogen, straight or branched C1-C6 alkyl or a pharmaceutically acceptable inorganic cation; R1 is ethyl or cyclopropyl; and R2 and R3 are the same or different and are selected from F, Cl, Br, CF3 and OCF3. The compounds are useful for the treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection, and malignant neoplasia. Pharmaceutical compositions containing the compounds, methods of using the compounds, and methods for preparing the compounds are also provided.
    Type: Application
    Filed: July 17, 2012
    Publication date: November 8, 2012
    Inventors: Helén Tuvesson Andersson, Ulf Vellmar, Ingrid Hallin, Leif Svenson, Ingela Fritzson
  • Anthranilic acid derivatives
    Patent number: 8263658
    Abstract: Compounds of formula (I) are provided, wherein X is CH?CH, CH2O wherein the oxygen atom is bound to ring B, or OCH2 wherein the oxygen atom is bound to ring A; Y is hydrogen, straight or branched C1-C6 alkyl or a pharmaceutically acceptable inorganic cation; R1 is ethyl or cyclopropyl; and R2 and R3 are the same or different and are selected from F, Cl, Br, CF3 and OCF3. The compounds are useful for the treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection, and malignant neoplasia. Pharmaceutical compositions comprising the compounds, methods of using the compounds, and methods for preparing the compounds are also provided.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: September 11, 2012
    Assignee: Chelsea Therapeutics, Inc.
    Inventors: Helén Tuvesson Andersson, Ulf Vellmar, Ingrid Hallin, Leif Svenson, Ingela Fritzson
  • ANTHRANILIC ACID DERIVATIVES
    Publication number: 20100029767
    Abstract: Compounds of formula (I) are provided, wherein X is CH?CH, CH2O wherein the oxygen atom is bound to ring B, or OCH2 wherein the oxygen atom is bound to ring A; Y is hydrogen, straight or branched C1-C6 alkyl or a pharmaceutically acceptable inorganic cation; R1 is ethyl or cyclopropyl; and R2 and R3 are the same or different and are selected from F, Cl, Br, CF3 and OCF3. The compounds are useful for the treatment of autoimmune diseases, inflammatory diseases, organ transplant rejection, and malignant neoplasia. Pharmaceutical compositions comprising the compounds, methods of using the compounds, and methods for preparing the compounds are also provided.
    Type: Application
    Filed: August 4, 2009
    Publication date: February 4, 2010
    Inventors: Helén Tuvesson Andersson, Ulf Vellmar, Ingrid Hallin, Leif Svensson, Ingela Fritzson